LabGenomics Co., Ltd.
084650.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$41.2B
Close$
Share Statistics
| Market cap | $41.20 Billion |
|---|---|
| Enterprise Value | $94.45 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4335.55 |
| Beta | 0.06 |
| Outstanding Shares | 14,848,000 |
Return
| Return on Equity | -34.87% |
|---|---|
| Return on Assets | -22.23% |
| Return on Invested Capital | -38.06% |
Valuation & Multiples
| P/E Ratio | -0.8 |
|---|---|
| PEG | 0.97 |
| Price to Sales | 0.47 |
| Price to Book Ratio | 0.25 |
| Enterprise Value to Revenue | 1.22 |
| Enterprise Value to EBIT | -1.4 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.66 |
| Debt to Equity | 0.42 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$53.40 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About LabGenomics Co., Ltd.
142 employees
CEO: Jae-Hak Ryu LabGenomics Co., Ltd. is a specialist in genetic molecular diagnostics, providing a diverse array of related products and services. The company's offerings encompass advanced technologies such as Next Generation Sequencing (NGS) and gene...